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label carefully 
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After years of anticipation, the results of 
the Asymptomatic Carotid Atherosclerosis Study 
(ACAS) were released to the lay press in September 
1994, were summarized for the medical community 
the following December) and were fully reported in 
May 1995. 2 In this investigation, 1659 patients at 39 
centers in the United States and Canada were 
prospectively randomized to receive either daily 
aspirin therapy and medical risk factor treatment or 
thc same precautions plus carotid endarterectomy 
(CEA) for asymptomatic 60% to 99% stenosis 
documented by Doppler ultrasound (duplex) scan- 
ning. The mean severity of lumen stenosis was 73% 
according to the angiograms that ultimately were 
available for 313 (38%) of the 834 patients in the 
medical cohort and for 741 (90%) of the 825 patients 
who were designated to have CEA. A total of 146 
patients (9%) did not undergo their assigned 
treatment-101 ( 2%) in the surgical imb of the 
trial and 45 (5%) in the medical l imb- but outcome 
data were analyzed on an intent-to-treat basis and are 
summarized at a median follow-up interval of 2.7 
years in Table I. 
The ACAS report deserves to be read carefully by 
every clinician but its fundamental conclusion is by 
now well known: CEA and appropriate adjunctive 
measures were found statistically to be superior to 
nonoperative treatment alone in the prevention of 
subsequent s rokes caused by asymptomatic 60% to 
99% carotid artery stenosis. Furthermore, the per- 
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ceived benefit of CEA appeared to be largely limited 
to men, who experienced a relative reduction in 
stroke risk of 66% in comparison tothe modest figure 
of 17% in women. 
The ACAS is a pivotal study, and I have 
attempted to place several of its findings into the 
perspective of what I believed I knew about asymp- 
tomatic arotid artery stenosis. First, although there 
is nothing intrinsically wrong with the method used 
to establish the severity of carotid artery stenosis in 
the ACAS protocol, it is not widely used outside the 
setting of several recent, randomized trials and could 
lead inadvertently to the overuse of CEA in patients 
having only intermediate degrees of stenosis by 
conventional measurement. Second, the estimated 
stroke rate among the patients not undergoing 
operation in the ACAS (11% at 5 years) seems rather 
low, at least compared with the risk of high-grade 
carotid artery stenosis that was predicted by some 
earlier, nonrandomized case series; this difference is
difficult o explain but suggests the need for further 
refinement in the selection of surgical candidates. 
Finally, some interesting findings previously have 
been reported concerning the respective severity of 
carotid artery stenosis in men and women with 
asymptomatic carotid bruits that may pertain to the 
outcome distinctions related to gender in the ACAS. 
MEASUREMENT OF STENOSIS 
As the moderator for the session on extracranial 
arterial disease at the postgraduate course in periph- 
eral vascular surgery during the Qctober 1994 
Clinical Congress of the American College of Sur- 
geons, I asked the members of the audience who 
already performed prophylactic CEA in selected 
patients to indicate whether they had decided to 
recommend surgical treatment for less severe stenosis 
because of the preliminary ACAS data that were 
available at that time. Using a computerized interac- 
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Table I. Summary of selected ACAS results 2
Outcome events* Risk reduction 
Randomized cohort No. Perioperative (%) 5-year (%) Estimate (%) 95% CI (%) 
All 
Surgical 825 2.3 5.1 53 22-72 
Medical 834 0.4 11.0 - - 
Men 
Surgical 544 1.7 4.1 66 36-82 
Medical 547 0.5 12.1 - - 
Women 
Surgical 281 3.6 7.3 17 96-65 
Medical 287 0 8.7 - 
Patients receiving 
assigned treatment 
Surgical 724 2.2 5.1 55 23-74 
Medical 789 0.4 11.5 - 
~Estimated incidence of 5-year ipsilateral strokes, or perioperative strokes or deaths occurring within 30 days of  randomization i the 
surgical group or within 42 days of  randomization i the medical group. 
tive device at each of their seats, approximately 55% 
of the audience responded that yes, they had. This 
vignette implies to me that some surgeons who 
otherwise had restricted CEA to symptom-free pa- 
tients with at least 75% to 80% stenosis had been 
persuaded to extend their indications to include 
patients with any stenosis exceeding 60% on the basis 
of what they then had heard about he ACAS results. 
I believe this would be a mistake because there is 
good reason to believe that 60% to 99% stenosis by 
the ACAS definition is virtually identical to the 
advanced severity of stenosis for which most sur- 
geons have performed prophylactic CEA during the 
past decade or so. It must be remembered that the 
ACAS used the diameter of the normal internal 
carotid artery (ICA) distal to the qualifying lesion as 
the reference point for its angiographic measure- 
ments and also to establish the duplex cut points 
(peak systolic or end-diastolic velocities) serving as its 
entry criteria. This is an important feature of the 
ACAS and one with which every carotid surgeon 
should become familiar. 
In the past, the duplex criteria for most noninva- 
sire vascular laboratories have been calibrated against 
a series of angiograms by comparing the diameter of 
the residual lumen to the estimated diameter of the 
"normal" upper segment of the carotid bulb in which 
such lesions occur in the vast majority of cases. The 
definition of truly severe stenosis may be slightly 
different at each duplex facility (i.e., ___ 70% to 75% 
at some, and ___80% at others), but each fairly 
represents what all of us usually have considered tobe 
relevant from a clinical standpoint. However, with 
the exception of the European Carotid Surgery 
Trial, s most randomized studies like the ACAS 
instead have used the distal ICA for their reference 
point. 46 Unless an allowance is made for this, the 
patients in the ACAS will appear to have had much 
less stenosis by traditional standards than actually was 
the case.7 According to Williams and Nicolaides,  the 
diameter of the carotid bulb is, on average, 1.83 times 
the diameter of the distal ICA. The reader can tinker 
with the mathematics of this relationship as well as I, 
but my calculations indicate that 60% stenosis of the 
ICA corresponds to a residual lumen representing 
about 78% stenosis in the carotid bulb. Thus there is 
no reason for surgeons who had recommended 
prophylactic CEA to patients having at least 75% to 
80% stenosis on the basis of conventional duplex or 
angiographic measurements before the ACAS report 
to change their surgical indications now. 
Two recent studies, both from vascular labo- 
ratories with the bulb used as the reference point, 
suggest that intermediate d grees of asymptomatic 
carotid artery stenosis (either 50% to 79% or 60% 
to 79%) by duplex scanning are associated with an 
annual stroke risk of only 1%; many, if not most 
of these strokes tended to occur in patients whose 
lesions had worsened to a severity of at least 80% 
stenosis while under observation. 9,1~ A number of 
other reports also have concluded that both tran- 
sient ischemic attacks and strokes are significantly 
more likely to occur when serial duplex scans 
demonstrate r latively rapid progression i  the se- 
verity of carotid artery stenosis) ~13 At my own 
center, patients who are found to have intermediate 
carotid artery stenosis on an initial duplex scan are 
encouraged to return for another scan in 6 months 
or so, simply to determine whether their disease is 
in a phase of rapid progression or may have been 
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very close to being classified as 80% to 99% stenosis 
in the first place. Provided their lesions remain stable 
during this interval, surveillance is continued with 
annual duplex scans as long as these patients remain 
symptom free with daily aspirin therapy. Elective 
surgical treatment is reserved for those who even- 
tually develop 80% to 99% stenosis, or approxi- 
mately 10% of our patients per year. 1~ Nothing in 
the ACAS data indicates that we should abandon 
this policy. 
STROK~E RISK REDUCTION 
Although the ACAS results generally were favor- 
able to surgical treatment, hey still must be kept in 
perspective (Table I). The estimated 5-year stroke 
rate was 11% among 834 patients who were ran- 
domized to nonoperative treatment, compared with 
5.1% for 825 patients who were assigned to the 
surgical limb of the trial (relative risk reduction, 53%; 
95% confidence interval, 22% to 72%; p = 0.004). 
Nevertheless, the absolute difference in stroke risk of 
just 5.9% between the two cohorts is not overwhelm- 
ing and owes much of its significance to the fact that 
the immediate postoperative stroke and mortality 
rate for 724 patients who actually received CEA was 
an exemplary 1.5%. As a practical matter, the 
superiority of CEA performed by the vetted surgeons 
who qualified to participate in the ACAS may not yet 
be sustainable in a lot of other settings. In summary 
the ACAS report requires cautious interpretation if it 
really means what it says. 
I suspect hat most surgeons who performed 
prophylactic CEA for severe stenosis before the 
ACAS report probably assumed that they were 
preventing more strokes than its data appear to 
indicate. I certainly did. Several nonrandomized 
studies have suggested that severe stenosis- 80% by 
conventional measurement, corresponding to60% in 
the ACAS-is associated with an annual stroke risk 
exceeding 5%, compared with an annual risk of about 
1% for intermediate degrees of stenosis (Table II). 
According to the ACAS, however, the annual stroke 
risk for severe stenosis i  merely 2%. This means that, 
rather than a ratio of approximately 5:1, 19 CEAs 
would be necessary to prevent asingle stroke within 
the first few years after the discovery of severe carotid 
artery stenosis.14 The new odds do not appeal to me 
nearly as much as the old ones did, and I am sure that 
most healthcare economists would feel the same way. 
If the ACAS is correct, then perhaps we need to 
become more discriminatory in our selection of 
candidates for CEA even within the category of 
"severe" stenosis. An analysis of the contralateral 
carotid arteries in 2295 patients entered into the 
European Carotid Surgery Trial, for instance, re- 
vealed that the 3-year stroke rates on the asymptom- 
atic side were 5.7% for 70% to 99% stenosis 
(n = 127), 9.8% for 80% to 89% stenosis, and 14% 
for 90% to 99% stenosis. 15 Nevertheless, whereas 
90% stenosis probably is more dangerous than 80% 
stenosis, the distinction between them may surpass 
the capabilities of the average vascular laboratory, or 
so many serial duplex scans may be necessary to 
determine progression from one point to another 
that an attempt to make such a distinction becomes 
unworkable. 
Is it instead possible that the ACAS is not entirely 
correct in its estimate of the 5-year stroke risk in 
patients who do not undergo peration with severe 
stenosis? Whatever I have to say in this regard 
represents sheer speculation, but, because a trial as 
important as the ACAS is going to be subjected to a 
good deal of it anyway, here is mine. First, the 5-year 
stroke risk in the ACAS report was extrapolated from 
data that were collected uring a median follow-up 
interval of 2.7 years, so this risk conceivably could 
have been higher if the trial had not been terminated. 
(Conversely, it could have been lower, but the studies 
cited in Table II seem to mitigate against this.) 
Second, despite very conceivable effort to do so, it 
must have been exceedingly difficult to verify the 
reproducibility of duplex results at the 39 centers 
participating in the ACAS during a period of 6 years 
in which both their equipment and their personnel 
are bound to have undergone changes. The aspect of 
the ACAS with which I always have been least 
comfortable is the possibility that it might include 
too many patients who had only "intermediate" 
stenosis by conventional standards of measurement, 
and, for that reason, would not have been at a 
predictable risk for stroke without CEA. If they exist, 
these patients probably would have been recruited 
into the trial at the low range of its entry criteria. In 
this respect, it can only be noted that nearly half 
(42%) of the 642 patients for whom angiograms 
were obtained had only 60% to 69% carotid artery 
stenosis. 
OUTCOME IN WOMEN 
As indicated in Table I, CEA was ass&iated with 
less reduction in the estimated 5-year event rate 
among women in the ACAS (17%) than among men 
(66%). Although this difference did not attain 
statistical significance (p = 0.10), it understandably 
became one of the newsworthy features of the trial at 
the time of its preliminary disclosures to the lay press. 
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Table II .  Ipsilateral stroke rates for previous case series of severe and intermediate carotid artery 
stenosis by conventional measurement 
Series Year Carotid artery stenosis No. Follow-up (yrs.) Stroke rate (%) 
Severe stenosis 
Hertzer et al. 21 1986 
Moneta et al. 22 1987 
Caracci et al. 23 1989 
Intermediate stenosis 
Hertzer et al. 21 1986 
Johnson et al. 9 1995 
Olin et al.l~ Submitted 
70%-89% 51 4 24 
90%-99% 18 4 33 
80%-99% 73 2 19 
75%-99% 62 2 18 
50%-69% 88 4 4 
50%-79% 232 7 11 
60%-79% 465 4 4 
I f  there indeed is a trend toward gender distinctions 
in the ACAS, at least part of it may be attributed to 
the fact that the incidence of major perioperative 
complications was slightly higher for the women in 
the surgical cohort (3.6%) than it was for the men 
(1.7%). Although these results reconfirm that the 
benefit of CEA for asymptomatic stenosis may be 
influenced by even a marginal elevation in surgical 
risk, they should not necessarily be interpreted to 
mean that women are preordained to have a higher 
incidence of perioperative complications. During the 
past 6 years, the members of my own department 
have performed CEA for asymptomatic stenosis in 
1078 patients; the mortality rate was 0.4% irrespec- 
tive of gender, and the stroke rate in the 370 women 
(1.6%) was about he same as in the 708 men (1.3%). 
The fact remains that CEA still seems to have 
conferred less benefit on the women in the ACAS 
than the men even if all patients who had perioper- 
ative complications are excluded from consideration 
(5-year relative risk reduction of 56% and 79%, 
respectively). 
Therefore it appears to be just as important that 
the 5-year event rate for the women in the medical 
limb of the trial (8.7%) was 28% lower than it was 
for men (12.1%). This strikes me as something of an 
unexpected finding because, according to conven- 
tional wisdom, aspirin therapy is supposed to be less 
effective in women. Everything considered, the 
absolute difference was just 1.4% between the 5-year 
event rates for women who underwent CEA (7.3%) 
and for those who did not (8.7%). There has to be 
some reasonable xplanation for this if we are to 
continue to recommend prophylactic CEA to 
women, and my guess is that he estimated stroke rate 
for women in the medical limb of the ACAS is too 
low to represent the risk of truly severe carotid artery 
stenosis. Several previous tudies have demonstrated 
that asymptomatic carotid bruits are more common 
in women and, 0f particular interest, hat they tend to 
occur in the presence of less stenosis than usually is 
the case in men. 11,16,17 Chambers and Norris 11 
described the results of  duplex scanning in a total of 
500 patients with asymptomatic bruits; women 
comprised 58% of this series, yet their incidence of 
___ 75% carotid artery stenosis (16%) was only half of 
that in men (32%). In an earlier eport from my own 
center, asymptomatic bruits were discovered in 57 
(29%) of 194 women and in 87 (17%) of $11 men 
(p = 0.0005) who were candidates for non-carotid 
vascular surgery) 7 Angiography revealed that these 
bruits were associated with "--75% carotid artery 
stenosis in 31% of the women, compared to 54% of 
the men (p = 0.0009); furthermore, the incidence of 
___ 90% stenosis was only 9% in the women, com- 
pared to 23% in the men (p = 0.042). 
Unless I am mistaken, a substantial number of 
women entered the medical limb of the ACAS on the 
basis of 60% to 69% carotid artery stenosis-a 
criterion that, with very tittle margin for duplex 
scanning error, could be quite comparable to the 
conventional range of intermediate stenosis for which 
stroke risk appears to be relatively low. I may be 
wrong, but otherwise I have no good explanation for 
why severe, uncorrected carotid artery stenosis 
should be less dangerous in women than in men. 
Some of my other remarks concerning the ACAS 
results are purely speculative, but there is legitimate 
reason to be concerned that many clinicians do not 
yet recognize that its definition of 60% to 99% 
stenosis is different from their own. I-Iobson and 
Strandness 18already have pointed out the necessity to 
reconcile the measurement of  carotid artery stenosis 
to correspond with the method used in most of the 
randomized trials, and Moneta et al.19.20 have pub- 
lished new duplex velocity criteria with which to do 
so. In the meantime, vascular surgeons find them- 
selves in the unaccustomed but enviable position of 
counseling restraint to referring physicians with 
respect to the severity of  asymptomatic carotid artery 
stenosis that justifies elective CEA. Like most sur- 
geons, I believe some latitude from strict guidelines 
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clearly is necessary in the selection of certain patients 
with symptoms for CEA in the presence of complex 
plaque ulceration or impressive cortical ischemic 
events associated with only intermediate degrees of 
carotid artery stenosis. But prophylactic CEA for 
asymptomatic 60% stenosis as it generally has been 
measured in the past? No way. 
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